The Exploration of Ink Formulations in Binder Jet 3D Printing Drugs

Overview

Journal 3D Print Addit Manuf

Date 2024 Oct 3

PMID 39360131

Authors

Shanshan Wang

En Liang

Xiaolu Han

Hui Zhang

Conghui Li

Mingyuan Li

Peng Yu

Zengming Wang

Xiang Gao

Aiping Zheng

Affiliations

Soon will be listed here.

Abstract

The application of binder jet 3D printing technology in the pharmaceutical field is developing rapidly. The properties of the ink are very important, affecting the stability of the ejection and the precision of the finished product, but there is a great lack of research on pharmaceutical inks. This study used solvents and excipients commonly used in pharmaceuticals to quantify the printability of inks using printability value theory, while using an ink-jet printing and observation platform to analyze the droplet ejection state of different composition inks from microscopic level. Studies have shown that compared to ethanol, the ejection effect of droplets was better when isopropanol was added to the ink, and the proportion added should not be greater than 40%; as the molecular weight of polyvinylpyrrolidone (PVP) increased, the concentration of PVP tolerated by the ink decreased; glycerin has a high ejection efficiency when the proportion is within 10%. In summary, a superior ink formulation of 40% aqueous isopropanol plus 0.1% PVP K30 and 4% glycerin was obtained. With this ink, levetiracetam dispersible tablets were prepared with a smooth printing process and the tablets had good appearance, good mechanical properties, and rapid release. This study provides a mutual validation of the value theory and the results of droplet ejection and tablet printing, while providing good ideas.

References

Yu D, Yang X, Huang W, Liu J, Wang Y, Xu H . Tablets with material gradients fabricated by three-dimensional printing. J Pharm Sci. 2007; 96(9):2446-56. DOI: 10.1002/jps.20864. View

Di Prima M, Coburn J, Hwang D, Kelly J, Khairuzzaman A, Ricles L . Additively manufactured medical products - the FDA perspective. 3D Print Med. 2018; 2. PMC: 6027614. DOI: 10.1186/s41205-016-0005-9. View

Wang S, Han X, Gao X, Zhang H, Li C, Duan S . The Evaluation and Exploration of Piezoelectric Parameter Optimization for Droplet Ejection in Binder Jet 3D Printing Drugs. 3D Print Addit Manuf. 2023; 10(5):1090-1100. PMC: 10599426. DOI: 10.1089/3dp.2022.0131. View

Tian P, Yang F, Xu Y, Lin M, Yu L, Lin W . Oral disintegrating patient-tailored tablets of warfarin sodium produced by 3D printing. Drug Dev Ind Pharm. 2018; 44(12):1918-1923. DOI: 10.1080/03639045.2018.1503291. View

Chen X, Wang S, Wu J, Duan S, Wang X, Hong X . The Application and Challenge of Binder Jet 3D Printing Technology in Pharmaceutical Manufacturing. Pharmaceutics. 2022; 14(12). PMC: 9786002. DOI: 10.3390/pharmaceutics14122589. View

Wang J, Zhang Y, Aghda N, Pillai A, Thakkar R, Nokhodchi A . Emerging 3D printing technologies for drug delivery devices: Current status and future perspective. Adv Drug Deliv Rev. 2021; 174:294-316. DOI: 10.1016/j.addr.2021.04.019. View

Hong X, Han X, Li X, Li J, Wang Z, Zheng A . Binder Jet 3D Printing of Compound LEV-PN Dispersible Tablets: An Innovative Approach for Fabricating Drug Systems with Multicompartmental Structures. Pharmaceutics. 2021; 13(11). PMC: 8623818. DOI: 10.3390/pharmaceutics13111780. View

Gao T, Gillispie G, Copus J, Pr A, Seol Y, Atala A . Optimization of gelatin-alginate composite bioink printability using rheological parameters: a systematic approach. Biofabrication. 2018; 10(3):034106. PMC: 6040670. DOI: 10.1088/1758-5090/aacdc7. View

Wang Z, Han X, Chen R, Li J, Gao J, Zhang H . Innovative color jet 3D printing of levetiracetam personalized paediatric preparations. Asian J Pharm Sci. 2021; 16(3):374-386. PMC: 8261256. DOI: 10.1016/j.ajps.2021.02.003. View

10.

Yu D, Shen X, Branford-White C, Zhu L, White K, Yang X . Novel oral fast-disintegrating drug delivery devices with predefined inner structure fabricated by Three-Dimensional Printing. J Pharm Pharmacol. 2009; 61(3):323-9. DOI: 10.1211/jpp/61.03.0006. View

11.

Cui X, Li J, Hartanto Y, Durham M, Tang J, Zhang H . Advances in Extrusion 3D Bioprinting: A Focus on Multicomponent Hydrogel-Based Bioinks. Adv Healthc Mater. 2020; 9(15):e1901648. DOI: 10.1002/adhm.201901648. View

12.

Lin T, Sun X, Hu Y, Mu W, Sun Y, Zhang D . Blended host ink for solution processing high performance phosphorescent OLEDs. Sci Rep. 2019; 9(1):6845. PMC: 6497667. DOI: 10.1038/s41598-019-43359-4. View

13.

Goole J, Amighi K . 3D printing in pharmaceutics: A new tool for designing customized drug delivery systems. Int J Pharm. 2016; 499(1-2):376-394. DOI: 10.1016/j.ijpharm.2015.12.071. View

14.

Xu C, Zhang M, Huang Y, Ogale A, Fu J, Markwald R . Study of droplet formation process during drop-on-demand inkjetting of living cell-laden bioink. Langmuir. 2014; 30(30):9130-8. DOI: 10.1021/la501430x. View

15.

Sen K, Mehta T, Sansare S, Sharifi L, Ma A, Chaudhuri B . Pharmaceutical applications of powder-based binder jet 3D printing process - A review. Adv Drug Deliv Rev. 2021; 177:113943. DOI: 10.1016/j.addr.2021.113943. View

16.

Chang S, Li S, Kowsari K, Shetty A, Sorrells L, Sen K . Binder-Jet 3D Printing of Indomethacin-laden Pharmaceutical Dosage Forms. J Pharm Sci. 2020; 109(10):3054-3063. DOI: 10.1016/j.xphs.2020.06.027. View

17.

Jang D, Kim D, Moon J . Influence of fluid physical properties on ink-jet printability. Langmuir. 2009; 25(5):2629-35. DOI: 10.1021/la900059m. View

18.

Lamichhane S, Park J, Sohn D, Lee S . Customized Novel Design of 3D Printed Pregabalin Tablets for Intra-Gastric Floating and Controlled Release Using Fused Deposition Modeling. Pharmaceutics. 2019; 11(11). PMC: 6920939. DOI: 10.3390/pharmaceutics11110564. View

19.

Song , SPRINGER . Determination of Interfacial Tension from the Profile of a Pendant Drop Using Computer-Aided Image Processing. J Colloid Interface Sci. 1996; 184(1):77-91. View

20.

Li Z, Huang S, Liu Y, Yao B, Hu T, Shi H . Tuning Alginate-Gelatin Bioink Properties by Varying Solvent and Their Impact on Stem Cell Behavior. Sci Rep. 2018; 8(1):8020. PMC: 5964146. DOI: 10.1038/s41598-018-26407-3. View